Dyne Therapeutics
Price & Volume
Stats
See more52W Range | $8.06-$25 |
Market Cap | $2.9B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.47 |
News
See moreYahoo Finance • 17 days ago
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Clearbridge Small Cap Growth Strategy Added Dyne Therapeutics (DYN) in Q4
Yahoo Finance • 2 months ago
This Biotech Was Quietly Bought Before a $58 Per Share Takeout
Yahoo Finance • 2 months ago
Dyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
About
CEO | Mr. John G. Cox M.B.A. |
CFO | Mr. Erick J. Lucera C.F.A., C.P.A. |
Address | 1560 Trapelo Road, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 258 |